DISCLAIMERThe information and materials accessed through or made available for use on any of our Sites, including, any information about diseases, conditions, treatments, or medicines, are for informational purposes only. The Content is not intended to be and is not a substitute for professional medical advice, diagnosis, or treatment, and your participation on our Sites does not create a healthcare professional-patient relationship. You should consult a doctor or other qualified health care professional regarding any questions you have about your health or before making any decisions related to your health or wellness. Call your doctor or 911 immediately if you think you may have a medical emergency.
Trusted Resources: News & Events
Latest announcements and gatherings
The University of Illinois at Chicago has been awarded a $4.6 million grant from the National Heart, Lung, and Blood Institute to study the molecular neurobiology of chronic pain in patients with sickle cell disease and to develop potential new drug treatments.
While there have been many advances in managing the disease and acute pain crises, researchers still do not know much about how and why patients experience chronic pain.
The new funding will provide an opportunity for investigators to refine their tools and develop new therapeutic leads for treating chronic pain in sickle cell disease. They hope to identify various molecular mechanisms and explore ways to target one or more of these mechanisms for controlling pain in sickle cell disease.
education & researchSickle cell pain in the emergency departmentSickle cell disease is characterized by ...
education & researchEpisodic Patterns of High Emergency Department Utilization Among Sickle Cell Disease PatientsBackground: High utilization of emergenc...
people & placesFondation Pierre FabreRecognized as a public utility since 199...
people & placesCharles T. Quinn, MD, MSDr. Quinn is Associate Professor of clin...
people & placesMarsha Treadwell, PhDMarsha J. Treadwell, PhD, is a clinical ...
news & eventsDoris Duke Charitable Foundation awards grant to Critical Path InstituteIn a continuing effort to spur advance...
news & eventsSCDAA Teams with MedicAlert Foundation to Improve Emergency Outcomes During Sickle Cell Crises[Hanover, Md., June 26, 2023] – The Si...
send a message
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
Support for this site is provided by
This platform is made possible through a partnership with the Sickle Cell Disease Association of America, Inc. (SCDAA) and its member organizations. SCDAA's mission is to advocate for people affected by sickle cell conditions and empower community-based organizations to maximize quality of life and raise public consciousness while advancing the search for a universal cure.